Dr. Ravish Patel has extensively work for Biosimilar product development for regulated and Semi-regulated markets especially monoclonal antibody products. Widely experienced and skilled in protein characterization with expertise in Cell-based and binding assay (Bioassay) and physicochemical characterization, knowledge in experimental investigations (in vitro and ex vivo) related to immunosafety and immunotoxicological mechanisms. He ahs good understanding of GMP/GLP and general regulatory requirements for biotherapeutics. Ravish is well-versed with EP and USP guidelines for many biopharmaceutical drugs. Backed by 17 years of R & D experience. Ravish was associated with Sun Pharma, Sun, Wockhardt Limited, EPYGEN Biotech , Cipla Limited, Cadial pharma, Intas Biotech. Dr. Ravish received his PhD in Biotechnology from the Nirma University.